BELLUS Health Analysis
| BLUDelisted Stock | USD 14.74 0.00 0.00% |
BELLUS Health is overvalued with Real Value of 10.77 and Hype Value of 14.74. The main objective of BELLUS Health delisted stock analysis is to determine its intrinsic value, which is an estimate of what BELLUS Health is worth, separate from its market price. There are two main types of BELLUS Health's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect BELLUS Health's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of BELLUS Health's stock to identify patterns and trends that may indicate its future price movements.
The BELLUS Health stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. BELLUS Health is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. BELLUS Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BELLUS Health's ongoing operational relationships across important fundamental and technical indicators.
BELLUS |
BELLUS Stock Analysis Notes
About 90.0% of the company shares are held by institutions such as insurance companies. The book value of BELLUS Health was currently reported as 2.91. The company recorded a loss per share of 0.73. BELLUS Health last dividend was issued on the 19th of August 2019. The entity had 1:3.6 split on the 19th of August 2019. BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people. For more info on BELLUS Health please contact Mark Levy at 450 680 4500 or go to https://www.bellushealth.com.BELLUS Health Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. BELLUS Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding BELLUS Health or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| BELLUS Health is not yet fully synchronised with the market data | |
| BELLUS Health has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 16 K. Reported Net Loss for the year was (76.08 M) with profit before taxes, overhead, and interest of 16 K. | |
| BELLUS Health has about 220.14 M in cash with (77.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.75. | |
| Over 90.0% of the company shares are held by institutions such as insurance companies |
BELLUS Health Upcoming and Recent Events
Earnings reports are used by BELLUS Health to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to BELLUS Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 9th of August 2023 Upcoming Quarterly Report | View | |
| 13th of November 2023 Next Financial Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View | |
| 19th of March 2024 Next Fiscal Year End | View | |
| 31st of March 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
BELLUS Market Capitalization
The company currently falls under 'Mid-Cap' category with a total capitalization of 1.87 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BELLUS Health's market, we take the total number of its shares issued and multiply it by BELLUS Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.BELLUS Health Predictive Daily Indicators
BELLUS Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BELLUS Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About BELLUS Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BELLUS Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BELLUS shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as BELLUS Health. By using and applying BELLUS Stock analysis, traders can create a robust methodology for identifying BELLUS entry and exit points for their positions.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BELLUS Health to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in BELLUS Stock
If you are still planning to invest in BELLUS Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BELLUS Health's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |